Many studies recently reported that HGF induced resistance to reversible EGFT-TKIs in EGFR mutant lung cancer cells by activating Met and the downstream phosphoinositide 3-kinase (PI3K)/Akt pathway [11–14, 31, 32]. The gene discussed is PIK3CA; the disease is lung carcinoma.